Vivo Bio Tech is a full service Pre-Clinical CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD - GLP, AAALAC & IND guidelines. The company offers services in the areas of In vivo & In vitro toxicity studies, Pharmacological investigations, Pharmacokinetic & toxicokinetic studies, Genotoxicity screening, Analytical services etc. Our experienced & skilled talented scientists offer advice on defining drug development paths tailored to specific molecules.
Our Experienced Scientific team provides both regulatory and non-regulatory IND enabling preclinical development services. We are capable of screening & evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology, our scientists can provide design & development of syngeneic / xenograft models for evaluation of anti-cancer agents. Further, our scientists can customize In vivo DMPK studies to help profile your drug candidate in both rodent and non-rodent animal models.
Vivo Bio Tech offers pioneering methodologies for support backed by precise service level agreements to ensure comfort of client through the period of the study & thereafter. We have very experienced scientists with proven capabilities in drug development. We have a sophisticated facility in this region. The following are the advantages of partnering –
Highest Quality Standards : At Vivo Bio Tech, we believe that a client requires delivering confirmable results for all regulatory studies, hence, all the study procedures are developed and validated to meet current OECD - GLP guidelines. The scheme of quality assurance available at Vivo Bio Tech strongly adheres to the requirements of OECD and FDA regulations.
Regulatory Support Services : Our team of experts have proven expertise for moving lead candidates to IND and subsequent market approval. Our experts can suggest you the suitable research options enabling you quick turn-around submissions to regulatory agencies.
End-to-End Integrated Services : We offer broad range of services ranging from In vitro to preclinical development addressing the full service lifecycle, both within and beyond the studies.
Fast Turn around Time : With the all the infrastructure located in vicinity, all the Biologic Research, In vitro and In vivo services requirement of the sponsor is addressed, thereby minimizing cost and turn-around time.
Seamless Facility Operations : With iBMS system, our facility is under constant monitoring & surveillance for all the activities being carried out. With restricted entries to personnel to different areas of the buildings based on their predefined roles, our facility defines the right environment to carry out all your research needs.
Cost Effectiveness : Owing to the location benefit (Asia-Pacific), Vivo Bio Tech offers cost effective solutions within the stipulated time lines without compromising on the quality of deliverables.
One stop Solution : Vivo is moving faster to become one stop solution for product testing, Vivo has all test systems such as rodents, non-rodents large animals, birds etc. In one word Vivo has "Daphnia to Dog" and "Pigeon to Pig".
Media Inquiries :
Cyagen Biosciences, Inc.
Mr Ashok Basamsetti
Manager - Business Development
P. +91 96769 64699
Vivo Bio Tech Ltd.
Mr Chandrasekhar Patnaik B.com, ACS
Chief Business Officer
P. +91 98482 86307